55 related articles for article (PubMed ID: 19040998)
21. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Chappell WH; Abrams SL; Wong EW; Chang F; Lehmann B; Terrian DM; Milella M; Tafuri A; Stivala F; Libra M; Basecke J; Evangelisti C; Martelli AM; Franklin RA
Biochim Biophys Acta; 2007 Aug; 1773(8):1263-84. PubMed ID: 17126425
[TBL] [Abstract][Full Text] [Related]
22. Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?
Cristea S; Sage J
J Thorac Oncol; 2016 Aug; 11(8):1233-1241. PubMed ID: 27133774
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cell-cell contact molecules and the metastatic phenotype of medullary thyroid carcinoma by the Raf-1/MEK/ERK pathway.
Ning L; Kunnimalaiyaan M; Chen H
Surgery; 2008 Dec; 144(6):920-4; discussion 924-5. PubMed ID: 19040998
[TBL] [Abstract][Full Text] [Related]
24. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
Sippel RS; Carpenter JE; Kunnimalaiyaan M; Chen H
Surgery; 2003 Dec; 134(6):866-71; discussion 871-3. PubMed ID: 14668716
[TBL] [Abstract][Full Text] [Related]
25. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
26. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
Park JI; Strock CJ; Ball DW; Nelkin BD
Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453
[TBL] [Abstract][Full Text] [Related]
27. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
28. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
[TBL] [Abstract][Full Text] [Related]
29. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
[TBL] [Abstract][Full Text] [Related]
30. Medullary thyroid cancer: monitoring and therapy.
Ball DW
Endocrinol Metab Clin North Am; 2007 Sep; 36(3):823-37, viii. PubMed ID: 17673130
[TBL] [Abstract][Full Text] [Related]
31. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
Wu C; Cipollone J; Maines-Bandiera S; Tan C; Karsan A; Auersperg N; Roskelley CD
Differentiation; 2008 Feb; 76(2):193-205. PubMed ID: 17608733
[TBL] [Abstract][Full Text] [Related]
32. Focal adhesion kinase is negatively regulated by phosphorylation at tyrosine 407.
Lim Y; Park H; Jeon J; Han I; Kim J; Jho EH; Oh ES
J Biol Chem; 2007 Apr; 282(14):10398-404. PubMed ID: 17303567
[TBL] [Abstract][Full Text] [Related]
33. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis.
Park D; Kåresen R; Axcrona U; Noren T; Sauer T
APMIS; 2007 Jan; 115(1):52-65. PubMed ID: 17223851
[TBL] [Abstract][Full Text] [Related]
34. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis.
Halbleib JM; Nelson WJ
Genes Dev; 2006 Dec; 20(23):3199-214. PubMed ID: 17158740
[TBL] [Abstract][Full Text] [Related]
35. Wnt/FZD signaling and colorectal cancer morphogenesis.
Hlubek F; Spaderna S; Schmalhofer O; Jung A; Kirchner T; Brabletz T
Front Biosci; 2007 Jan; 12():458-70. PubMed ID: 17127310
[TBL] [Abstract][Full Text] [Related]
36. In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer.
Vaccaro A; Chen H; Kunnimalaiyaan M
Anticancer Drugs; 2006 Aug; 17(7):849-53. PubMed ID: 16926634
[TBL] [Abstract][Full Text] [Related]
37. The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
Kunnimalaiyaan M; Chen H
Anticancer Drugs; 2006 Feb; 17(2):139-42. PubMed ID: 16428931
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]